Current mechanistic concepts for PCa transition to aggressive, metastatic CRPC have highlighted the involvement of a hypoxic tumor environment [8], inflamed peri-prostatic adipose tissues [9], and inflammatory signaling pathways [10] that activate androgen receptors and promote PCa progression. The gene discussed is AR; the disease is posterior cortical atrophy.